CN105796685A - 一种制备治疗心肌梗死的中药组合物的方法 - Google Patents
一种制备治疗心肌梗死的中药组合物的方法 Download PDFInfo
- Publication number
- CN105796685A CN105796685A CN201610306368.XA CN201610306368A CN105796685A CN 105796685 A CN105796685 A CN 105796685A CN 201610306368 A CN201610306368 A CN 201610306368A CN 105796685 A CN105796685 A CN 105796685A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- medicine composition
- fructus
- myocardial infarction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000003814 drug Substances 0.000 title claims abstract description 49
- 239000000203 mixture Substances 0.000 title claims abstract description 40
- 208000010125 myocardial infarction Diseases 0.000 title claims abstract description 24
- 238000000034 method Methods 0.000 title claims abstract description 14
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 16
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 16
- 239000002994 raw material Substances 0.000 claims abstract description 12
- XOJVHLIYNSOZOO-SWOBOCGESA-N Arctiin Chemical compound C1=C(OC)C(OC)=CC=C1C[C@@H]1[C@@H](CC=2C=C(OC)C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)=CC=2)C(=O)OC1 XOJVHLIYNSOZOO-SWOBOCGESA-N 0.000 claims description 15
- 241000921449 Rhodobryum roseum Species 0.000 claims description 14
- 239000000706 filtrate Substances 0.000 claims description 12
- 238000002360 preparation method Methods 0.000 claims description 10
- 238000001914 filtration Methods 0.000 claims description 9
- 239000012567 medical material Substances 0.000 claims description 6
- XLYOFNOQVPJJNP-ZSJDYOACSA-N Heavy water Chemical compound [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 claims description 4
- 230000001476 alcoholic effect Effects 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 4
- 108010059892 Cellulase Proteins 0.000 claims description 3
- 229940106157 cellulase Drugs 0.000 claims description 3
- 239000000284 extract Substances 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 238000010298 pulverizing process Methods 0.000 claims description 3
- 238000010992 reflux Methods 0.000 claims description 3
- 239000002775 capsule Substances 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 239000006187 pill Substances 0.000 claims description 2
- 239000000843 powder Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 23
- 210000004369 blood Anatomy 0.000 abstract description 17
- 239000008280 blood Substances 0.000 abstract description 17
- 210000000952 spleen Anatomy 0.000 abstract description 8
- 230000017531 blood circulation Effects 0.000 abstract description 7
- 230000001737 promoting effect Effects 0.000 abstract description 6
- 230000008901 benefit Effects 0.000 abstract description 4
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract description 2
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract description 2
- 229940126680 traditional chinese medicines Drugs 0.000 abstract description 2
- 235000013399 edible fruits Nutrition 0.000 abstract 3
- 241000173529 Aconitum napellus Species 0.000 abstract 1
- 240000005528 Arctium lappa Species 0.000 abstract 1
- 235000003130 Arctium lappa Nutrition 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 244000247747 Coptis groenlandica Species 0.000 abstract 1
- 235000002991 Coptis groenlandica Nutrition 0.000 abstract 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 abstract 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 abstract 1
- 235000009685 Crataegus X maligna Nutrition 0.000 abstract 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 abstract 1
- 235000009486 Crataegus bullatus Nutrition 0.000 abstract 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 abstract 1
- 235000009682 Crataegus limnophila Nutrition 0.000 abstract 1
- 235000004423 Crataegus monogyna Nutrition 0.000 abstract 1
- 240000000171 Crataegus monogyna Species 0.000 abstract 1
- 235000002313 Crataegus paludosa Nutrition 0.000 abstract 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 abstract 1
- 240000006927 Foeniculum vulgare Species 0.000 abstract 1
- 235000004204 Foeniculum vulgare Nutrition 0.000 abstract 1
- 235000017443 Hedysarum boreale Nutrition 0.000 abstract 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 abstract 1
- 241000921453 Rhodobryum Species 0.000 abstract 1
- 241000220317 Rosa Species 0.000 abstract 1
- 241000913745 Spatholobus Species 0.000 abstract 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 201000010099 disease Diseases 0.000 description 8
- 230000002496 gastric effect Effects 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 8
- 230000007812 deficiency Effects 0.000 description 7
- 239000003172 expectorant agent Substances 0.000 description 7
- 230000003419 expectorant effect Effects 0.000 description 7
- 210000004185 liver Anatomy 0.000 description 7
- 230000001225 therapeutic effect Effects 0.000 description 7
- 210000002784 stomach Anatomy 0.000 description 6
- 206010062717 Increased upper airway secretion Diseases 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 230000036407 pain Effects 0.000 description 5
- 208000026435 phlegm Diseases 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 210000004204 blood vessel Anatomy 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000001647 drug administration Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 206010025482 malaise Diseases 0.000 description 3
- 230000008855 peristalsis Effects 0.000 description 3
- 239000013641 positive control Substances 0.000 description 3
- 238000010792 warming Methods 0.000 description 3
- 241000227129 Aconitum Species 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 206010008479 Chest Pain Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 241000218201 Ranunculaceae Species 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000036592 analgesia Effects 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 239000008899 fufang danshen Substances 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 230000000302 ischemic effect Effects 0.000 description 2
- 230000002045 lasting effect Effects 0.000 description 2
- 208000031225 myocardial ischemia Diseases 0.000 description 2
- 210000004165 myocardium Anatomy 0.000 description 2
- 230000001537 neural effect Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 210000002460 smooth muscle Anatomy 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- DWNBOPVKNPVNQG-LURJTMIESA-N (2s)-4-hydroxy-2-(propylamino)butanoic acid Chemical compound CCCN[C@H](C(O)=O)CCO DWNBOPVKNPVNQG-LURJTMIESA-N 0.000 description 1
- KSDSYIXRWHRPMN-UHFFFAOYSA-N 4'-O-beta-D-Galactopyranoside-6''-p-Coumaroylprunin-4',5,7-Trihydroxyflavanone Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC(O)=C3C(=O)C2)C=C1 KSDSYIXRWHRPMN-UHFFFAOYSA-N 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 201000006474 Brain Ischemia Diseases 0.000 description 1
- 241000345998 Calamus manan Species 0.000 description 1
- 244000080208 Canella winterana Species 0.000 description 1
- 235000008499 Canella winterana Nutrition 0.000 description 1
- 206010008120 Cerebral ischaemia Diseases 0.000 description 1
- 206010008469 Chest discomfort Diseases 0.000 description 1
- 241000756943 Codonopsis Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 241001278898 Glycyrrhiza inflata Species 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- DEMKZLAVQYISIA-ONJCETCRSA-N Liquiritin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)c1ccc([C@@H]2Oc3c(C(=O)C2)ccc(O)c3)cc1 DEMKZLAVQYISIA-ONJCETCRSA-N 0.000 description 1
- DEMKZLAVQYISIA-UHFFFAOYSA-N Liquirtin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-UHFFFAOYSA-N 0.000 description 1
- 208000008238 Muscle Spasticity Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 241000208343 Panax Species 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 241000800405 Spatholobus suberectus Species 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 206010000891 acute myocardial infarction Diseases 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 229940127089 cytotoxic agent Drugs 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- IZEKFCXSFNUWAM-UHFFFAOYSA-N dipyridamole Chemical compound C=12N=C(N(CCO)CCO)N=C(N3CCCCC3)C2=NC(N(CCO)CCO)=NC=1N1CCCCC1 IZEKFCXSFNUWAM-UHFFFAOYSA-N 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 230000005176 gastrointestinal motility Effects 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 230000001456 gonadotroph Effects 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- DEMKZLAVQYISIA-ZRWXNEIDSA-N liquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C([C@H]2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-ZRWXNEIDSA-N 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 235000021251 pulses Nutrition 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 235000012950 rattan cane Nutrition 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- GSZUGBAEBARHAW-UHFFFAOYSA-N sophoraflavone B Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C=2OC3=CC(O)=CC=C3C(=O)C=2)C=C1 GSZUGBAEBARHAW-UHFFFAOYSA-N 0.000 description 1
- 208000018198 spasticity Diseases 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 208000012991 uterine carcinoma Diseases 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/10—Bryophyta (mosses)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/40—Cornaceae (Dogwood family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/486—Millettia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/714—Aconitum (monkshood)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/718—Coptis (goldthread)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种制备治疗心肌梗死的中药组合物的方法,属于中药技术领域。该方法是以鸡血藤、牛蒡、三七、茴香、黄连、山楂、山茱萸、肉桂、附子、回心草和甘草为原料制得中药组合物。本发明制备的中药组合物具有活血祛瘀和补脾益气的功效,还具有疗效好、副作用低、服用方便和易于推广应用等优点。
Description
本申请是申请人临沂草之美医药科技有限公司提出的发明专利申请(发明名称为:一种治疗心肌梗死的中药组合物及其制备方法,申请号为:201510651817X,申请日为:2015年10月10日)的分案申请。
技术领域
本发明涉及一种制备治疗心肌梗死的中药组合物的方法,属于中药技术领域。
背景技术
心肌梗死是由于心肌持久严重缺血而引起的部分心肌坏死的病症,多发生于中年以后,发病时有剧烈而持久的性质类似心绞痛的前胸痛、心悸、气喘、脉搏微弱、血压降低等症状。本病发生率有逐年增高趋势,动脉硬化占急性心肌梗塞发病率的98%,患者40岁以上居多,且多伴有高血压,近半数有心绞痛病史。
在治疗方面,大致可分为两类:一是治标与治本,即“急则治其标,缓则治其本”;二是正治与反治,即“逆者正治,从者反治”,正治是逆其症候性质而治的一种常用治疗法则,反治是顺从疾病假象而治的一种治疗方法。现在中医认为冠心病心肌梗死的主要病机为本虚标实,本虚以气虚、阴虚为主,标实以气滞、血瘀、痰浊多见。古方中医提出了痰瘀互结理论,认为津液运化失司,停聚而成痰;血不循经,留于脉外或滞于脉中,造成血瘀痰停或痰聚碍血;或痰瘀互化,终至痰瘀阻滞于经脉,痰瘀互结而致病;并将心肌梗塞分为气阴两虚型、阳气虚弱型、痰瘀交阻气滞血瘀型等三型,分别治以益气养阴、益气温阳、化痰祛瘀。
中国申请专利201410113088.8公开了一种治疗心肌梗死的中药组合物,其制备原料包括:五倍子、金银花、杜仲、大蓟、川芎、地黄、蝉蜕、茯苓、白芍、党参和甘草,该中药组合物在治疗心肌梗死方面具有很好的治疗效果,具有显著的临床推广价值,但是在益气养阴、活血祛瘀等方面的效果不是十分显著。
发明内容
本发明要解决的技术问题是提供一种制备治疗心肌梗死的中药组合物的方法,该方法制得的中药组合物具有活血祛瘀和补脾益气的功效,还具有疗效好、副作用低、服用方便和易于推广应用等优点。
本发明制备的中药组合物由以下重量份数的原料制备而成:鸡血藤10-15份、牛蒡6-15份、三七10-15份、茴香6-15份、黄连3-9份、山楂9-12份、山茱萸6-12份、肉桂6-12份、附子3-10份、回心草6-9份和甘草1-10份。
优选地,所述中药组合物由以下重量份数的原料制备而成:鸡血藤10-12份、牛蒡6-10份、三七12-15份、茴香6-10份、黄连3-6份、山楂9-10份、山茱萸10-12份、肉桂8-12份、附子5-10份、回心草6-8份和甘草5-10份。
优选地,所述中药组合物由以下重量份数的原料制备而成:鸡血藤11份、牛蒡8份、三七13份、茴香9份、黄连5份、山楂9份、山茱萸11份、肉桂10份、附子7份、回心草7份和甘草6份。
优选地,所述中药组合物由以下重量份数的原料制备而成:鸡血藤12份、牛蒡10份、三七15份、茴香10份、黄连6份、山楂10份、山茱萸12份、肉桂12份、附子10份、回心草8份和甘草10份。
优选地,所述的中药组合物被制成片剂、胶囊剂、滴丸剂、颗粒剂或散剂。
本发明制备治疗心肌梗死的中药组合物的方法包括下述步骤:
(1)称取重量份鸡血藤10-15份,粉碎,加入药材重量2-5倍量体积分数为60-90%的乙醇溶液,再加入药材重量0.8%-1.5%的纤维素酶,在38-45℃下浸提1-3小时,然后在85-95℃回流提取1-2小时,过滤并保留鸡血藤滤渣,得到鸡血藤提取液;
(2)称取重量份牛蒡6-15份、三七10-15份、茴香6-15份、黄连3-9份、山楂9-12份、山茱萸6-12份、肉桂6-12份、附子3-10份、回心草6-9份和甘草1-10份,加入所述鸡血藤滤渣,粉碎,加入3-8倍量重水煮沸1-5小时,过滤,得到滤液,往滤渣中加入2-5倍重量的体积分数为60-90%的乙醇溶液,煮沸30-60分钟,过滤,得到滤液,合并两次滤液;
(3)将所述鸡血藤提取液与所述两次滤液混匀,浓缩至相对密度为1.20-1.35的稠膏,减压干燥,粉碎后过100-200目筛,即得中药组合物。
本发明所用组分的来源、性味、归经及功效:
鸡血藤:本品为豆科植物密花豆的干燥藤茎;味苦、甘,性温;归肝、肾经;补血,活血,通络。
牛蒡:为菊科草本直根类植物,牛蒡的纤维可以促进大肠蠕动,帮助排便,降低体内胆固醇,减少毒素、废物在体内积存,达到预防中风和防治胃癌、子宫癌的功效。西医认为它除了具有利尿、消积、祛痰止泄等药理作用外,还用于便秘、高血压、高胆固醇症的食疗。中医认为有疏风散热、宣肺透疹、解毒利咽等功效。
三七:为五加科植物三七的干燥根和根茎,具有散瘀止血,消肿定痛之功效。此外,还具有包括止血、抗血栓、促进造血、扩血管、降血压、抗心肌缺血、抗脑缺血、抗心律失常、抗动脉粥样硬化、抗炎、保肝、抗肿瘤、镇痛等作用,主要有效成分是PNS、PDS、PTS以及三七氨酸。
茴香:主要成分是茴香油,能刺激胃肠神经血管,促进消化液分泌,增加胃肠蠕动,排除积存的气体,所以有健胃、行气的功效;有时胃肠蠕动在兴奋后又会降低,因而有助于缓解痉挛、减轻疼痛。中医学上入药,性温,味辛,归肝、肾、脾、胃经;功能温肝肾,暖胃气、散塞结,散寒止痛,理气和胃。茴香还有抗溃疡、镇痛、性激素样作用等,茴香油有不同程度的抗菌作用。能刺激胃肠神经血管,促进唾液和胃液分泌,起到增进食欲,帮助消化的作用。适合脾胃虚寒。
黄连:本品为毛茛科植物黄连的干燥根茎;味苦,性寒;归心、脾、胃、肝、胆、大肠经;清热燥湿,泻火解毒。
山楂:含多种有机酸。口服后增强胃液酸度,提高胃蛋白酶活性,促进蛋白质的消化;山楂味酸,刺激胃黏膜促进胃液分泌;山楂中含脂肪酶,能促进脂肪的消化;山楂含有维生素C等成分,口服可增进食欲;山楂对胃肠运动功能具有调节作用,对痉挛状态的胃肠平滑肌有抑制作用,对松弛状态的平滑肌有兴奋作用,此外,山楂黄酮、水解产物增加缺血心肌营养性血流量,其中以山楂水解产物作用最强。山楂在增加冠状动脉血流量的同时,还能降低心肌耗氧量,提高氧利用率。
山茱萸:山茱萸肉含有丰富的营养物质和功能成分,明代李时珍的《本草纲目》集历代医家应用山茱萸的经验,把山茱萸列为补血固精、补益肝肾、调气、补虚、明目和强身之药。
肉桂:为樟科植物肉桂的干燥树皮;味辛、甘,性大热;归肾、脾、心、肝经;补火助阳,引火归源,散寒止痛,活血通经。
附子:又名乌头或附片,毛茛科、乌头属植物的子根的加工品。功能主治:回阳救逆、补火助阳,散寒止痛。
回心草:是一种中草药植物,植株体不大,味道微苦,可以作为心脏病或者其他精神类疾病的治疗。专治心脏病心慌、心悸,神经衰弱等症状。
甘草:为豆科植物甘草、胀果甘草或光果甘草的干燥根,甘草含有甘草酸、甘草甙等活性成分,具有清热解毒、补脾益气、祛痰止咳等功效。
与现有技术相比,本发明具有如下有益效果:
1、与现有其他治疗心肌梗死的中药药物相比,本发明制备的中药组合物在活血祛瘀和补脾益气等方面具有显著功效。
2、与化学治疗药物相比,本发明制备的中药组合物为天然纯中药制剂,不良反应显著降低,且该中药组合物作用全面,药物治疗效果更佳,从根源上治疗心肌梗死症,具有疗效好、服用方便和易于推广应用等优点。
具体实施方式
本领域技术人员应理解,以下实施例中所公开的技术代表本发明人发现的在本发明的实践中发挥良好作用的技术。然而,在所公开的具体实施方案中可以做出许多改变,并仍然获得相同或相似的结果,而不脱离本发明的精神和范围。
实施例1
中药组合物由以下重量份数的原料制备而成:鸡血藤10份、牛蒡10份、三七15份、茴香6份、黄连6份、山楂9份、山茱萸10份、肉桂12份、附子5份、回心草6份和甘草5份。
制备方法包括下述步骤:
A)称取鸡血藤,粉碎,加入药材重量5倍量体积分数为75%的乙醇,再加入药材重量1%的纤维素酶,在42℃下浸提2小时,然后在90℃回流提取2小时,过滤并保留鸡血藤滤渣,得到鸡血藤提取液;
B)称取牛蒡、三七、茴香、黄连、山楂、山茱萸、肉桂、附子、回心草和甘草,加入所述鸡血藤滤渣,粉碎,加入6倍重量水煮沸3小时,过滤,得到滤液,往滤渣中加入2倍重量的体积分数为75%的乙醇,煮沸45分钟,过滤,得到滤液,合并两次滤液;
C)将所述鸡血藤提取液与所述两次滤液混匀,浓缩至相对密度为1.25的稠膏,减压干燥,粉碎后过100目筛,即得本发明中药组合物。
实施例2
中药组合物由以下重量份数的原料制备而成:鸡血藤11份、牛蒡8份、三七13份、茴香9份、黄连5份、山楂9份、山茱萸11份、肉桂10份、附子7份、回心草7份和甘草6份。
制备方法与实施例1类似。
实施例3
中药组合物由以下重量份数的原料制备而成:鸡血藤12份、牛蒡10份、三七15份、茴香10份、黄连6份、山楂10份、山茱萸12份、肉桂12份、附子10份、回心草8份和甘草10份。
制备方法与实施例1类似。
临床疗效观察
1、病例选择:在300例心肌梗死临床患者志愿者中,男性150例,女性患者150例,年龄段为40-60岁,全部患者均具有典型的心肌梗死临床症状,且在性别、年龄、病程上无统计学差异。
2、诊断标准:
(1)典型心肌缺血症状(胸痛或胸闷不适);
(2)典型心电图变化;
(3)血清心肌酶升高。
3、疗效评定标准:
治愈:服用药物后,不适症状完全消失;
有效:服用药物后,不适症状减轻或部分消失;
无效:服用药物后,不适症状无变化;
总有效率=(治愈+有效)/总例数×100%。
4、服用方法:将300名患者志愿者随机分为3组,每组100人,分别为治疗A组、治疗B组和阳性对照组,治疗A组、治疗B组分别服用本发明实施例2、3制备得到的中药组合物,每日3次,每次10-20g,连服1个月。阳性对照组服用复方丹参滴丸(天津天士力制药股份有限公司,国药准字Z10950111),口服或舌下含服,一次10丸,一日3次,连服1个月。
5、治疗结果:如表1所示。
表1治疗结果
通过本发明制备的中药组合物与复方丹参滴丸的治疗效果进行比较,可以看出本发明制备的中药组合物治疗心肌梗死方面的显著疗效,治愈率达到80%,总有效率达到90%,高于阳性对照组的治愈率和总有效率,其中以治疗A组的治疗效果最好,可见,本发明制备的中药组合物的疗效好,痊愈率高,可作为治疗心肌梗死的治疗药物。
由于已经通过以上较佳实施例描述了本发明,在本发明的精神和/或范围内,任何针对本发明的替换/或组合来实施本发明,对于本领域的技术人员来说都是显而易见的,且包含在本发明之中。
Claims (5)
1.一种制备治疗心肌梗死的中药组合物的方法,其特征在于,所述制备方法包括下述步骤:
(1)称取重量份鸡血藤10-15份,粉碎,加入药材重量2-5倍量体积分数为60-90%的乙醇溶液,再加入药材重量0.8%-1.5%的纤维素酶,在38-45℃下浸提1-3小时,然后在85-95℃回流提取1-2小时,过滤并保留鸡血藤滤渣,得到鸡血藤提取液;
(2)称取重量份牛蒡6-15份、三七10-15份、茴香6-15份、黄连3-9份、山楂9-12份、山茱萸6-12份、肉桂6-12份、附子3-10份、回心草6-9份和甘草1-10份,加入所述鸡血藤滤渣,粉碎,加入3-8倍量重水煮沸1-5小时,过滤,得到滤液,往滤渣中加入2-5倍重量的体积分数为60-90%的乙醇溶液,煮沸30-60分钟,过滤,得到滤液,合并两次滤液;
(3)将所述鸡血藤提取液与所述两次滤液混匀,浓缩至相对密度为1.20-1.35的稠膏,减压干燥,粉碎后过100-200目筛,即得中药组合物。
2.如权利要求1所述的制备治疗心肌梗死的中药组合物的方法,其特征在于,所述中药组合物的原料的重量份如下:鸡血藤10-12份、牛蒡6-10份、三七12-15份、茴香6-10份、黄连3-6份、山楂9-10份、山茱萸10-12份、肉桂8-12份、附子5-10份、回心草6-8份和甘草5-10份。
3.如权利要求2所述的制备治疗心肌梗死的中药组合物的方法,其特征在于,所述中药组合物的原料的重量份如下:鸡血藤11份、牛蒡8份、三七13份、茴香9份、黄连5份、山楂9份、山茱萸11份、肉桂10份、附子7份、回心草7份和甘草6份。
4.如权利要求2所述的制备治疗心肌梗死的中药组合物的方法,其特征在于,所述中药组合物的原料的重量份如下:鸡血藤12份、牛蒡10份、三七15份、茴香10份、黄连6份、山楂10份、山茱萸12份、肉桂12份、附子10份、回心草8份和甘草10份。
5.如权利要求1-4任一所述的制备治疗心肌梗死的中药组合物的方法,其特征在于:所述中药组合物被制成片剂、胶囊剂、滴丸剂、颗粒剂或散剂。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610306368.XA CN105796685A (zh) | 2015-10-10 | 2015-10-10 | 一种制备治疗心肌梗死的中药组合物的方法 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610306368.XA CN105796685A (zh) | 2015-10-10 | 2015-10-10 | 一种制备治疗心肌梗死的中药组合物的方法 |
CN201510651817.XA CN105232677A (zh) | 2015-10-10 | 2015-10-10 | 一种治疗心肌梗死的中药组合物及其制备方法 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510651817.XA Division CN105232677A (zh) | 2015-10-10 | 2015-10-10 | 一种治疗心肌梗死的中药组合物及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105796685A true CN105796685A (zh) | 2016-07-27 |
Family
ID=55030675
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510651817.XA Withdrawn CN105232677A (zh) | 2015-10-10 | 2015-10-10 | 一种治疗心肌梗死的中药组合物及其制备方法 |
CN201610306368.XA Withdrawn CN105796685A (zh) | 2015-10-10 | 2015-10-10 | 一种制备治疗心肌梗死的中药组合物的方法 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510651817.XA Withdrawn CN105232677A (zh) | 2015-10-10 | 2015-10-10 | 一种治疗心肌梗死的中药组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (2) | CN105232677A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105213769A (zh) * | 2015-09-29 | 2016-01-06 | 罗奕珺 | 一种治疗心肌梗死的中药组合物及其制备方法 |
CN111467422A (zh) * | 2020-04-29 | 2020-07-31 | 佛山科学技术学院 | 治疗心肌梗死的中药组合物、药物制剂及其制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101716236A (zh) * | 2009-12-18 | 2010-06-02 | 潘根起 | 一种辅助治疗急性心肌梗死后左心功能不全的中药组合物及其制备方法 |
CN104940597A (zh) * | 2015-07-27 | 2015-09-30 | 青岛蓝盛洋医药生物科技有限责任公司 | 一种治疗心肌梗死的中药组合物及其制备方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102961540A (zh) * | 2012-11-29 | 2013-03-13 | 广西东兴市创新特色医药科技发展有限公司 | 一种治疗冠心病的药物及其制备方法 |
CN103816280B (zh) * | 2014-03-25 | 2015-05-13 | 崔新明 | 一种治疗心肌梗死的中药组合物及其应用 |
CN104225212A (zh) * | 2014-09-25 | 2014-12-24 | 刘会焕 | 一种治疗心肌梗塞的中药组合物 |
CN104225507A (zh) * | 2014-10-13 | 2014-12-24 | 崔银方 | 一种治疗脑溢血所致的肢体麻痹和疼痛的中药 |
CN104887747A (zh) * | 2015-07-06 | 2015-09-09 | 苗怡文 | 一种治疗脑血栓的中药组合物及其制备方法 |
-
2015
- 2015-10-10 CN CN201510651817.XA patent/CN105232677A/zh not_active Withdrawn
- 2015-10-10 CN CN201610306368.XA patent/CN105796685A/zh not_active Withdrawn
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101716236A (zh) * | 2009-12-18 | 2010-06-02 | 潘根起 | 一种辅助治疗急性心肌梗死后左心功能不全的中药组合物及其制备方法 |
CN104940597A (zh) * | 2015-07-27 | 2015-09-30 | 青岛蓝盛洋医药生物科技有限责任公司 | 一种治疗心肌梗死的中药组合物及其制备方法 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105213769A (zh) * | 2015-09-29 | 2016-01-06 | 罗奕珺 | 一种治疗心肌梗死的中药组合物及其制备方法 |
CN111467422A (zh) * | 2020-04-29 | 2020-07-31 | 佛山科学技术学院 | 治疗心肌梗死的中药组合物、药物制剂及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN105232677A (zh) | 2016-01-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104971215A (zh) | 一种治疗脾虚胃弱型慢性胃炎的中药组合物及其制备方法 | |
CN101518594A (zh) | 一种抗肿瘤及增强免疫力的中药制剂及其制备方法 | |
CN104940597A (zh) | 一种治疗心肌梗死的中药组合物及其制备方法 | |
CN113209194B (zh) | 一种治疗慢性胃炎的组合物及其制备方法和应用 | |
CN105796685A (zh) | 一种制备治疗心肌梗死的中药组合物的方法 | |
CN102210839A (zh) | 一种治疗冠心病的中药胶囊 | |
CN103705733B (zh) | 一种治疗心律不齐的中药胶囊及其制备方法 | |
CN102614466B (zh) | 一种治疗肺腺癌的中药制剂 | |
CN104771660A (zh) | 治疗胃癌的中药剂及制备方法 | |
CN104758676A (zh) | 一种用于治疗湿热中阻症胃脘痛的药物 | |
CN105396019A (zh) | 一种缓解肿瘤病人放疗反应的药物组合物 | |
CN105770760A (zh) | 主治胃溃疡的制剂及其制备方法 | |
CN105311425A (zh) | 含有艾叶的药物组合物用于制备治疗心肌梗死药物中的用途 | |
CN105687656A (zh) | 一种治疗脊髓炎的药物组合物及制作方法 | |
CN105213769A (zh) | 一种治疗心肌梗死的中药组合物及其制备方法 | |
CN104524535A (zh) | 一种治疗慢性肺源性心脏病的中药组合物及其制备方法 | |
CN105232962A (zh) | 一种用于制备治疗皮肤病的药物的中药组合物 | |
CN104888182A (zh) | 一种治疗产后腹痛的中药制剂及其制备方法 | |
CN104984060A (zh) | 治疗冠心病的中药剂 | |
CN105288036A (zh) | 一种治疗心肌梗死的药物组合物及其制备方法 | |
CN104784401A (zh) | 治疗胃癌的中药制剂 | |
CN103845671A (zh) | 心力衰竭温阳益气散及制备方法 | |
CN103623271B (zh) | 一种八味和胃口服制剂的制备方法 | |
CN111956724A (zh) | 一种治疗糖尿病的中药制剂及其制备方法 | |
CN107812087A (zh) | 一种治疗带下增多的中药组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20160727 |
|
WW01 | Invention patent application withdrawn after publication |